Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-cash Items (2023 - 2025)

InMed Pharmaceuticals' Non-cash Items history spans 3 years, with the latest figure at $161372.0 for Q4 2025.

  • For Q4 2025, Non-cash Items rose 17.88% year-over-year to $161372.0; the TTM value through Dec 2025 reached $161372.0, up 17.88%, while the annual FY2025 figure was $72549.0, 60.69% down from the prior year.
  • Non-cash Items reached $161372.0 in Q4 2025 per INM's latest filing, up from $50055.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $187634.0 in Q4 2023 to a low of $42297.0 in Q3 2023.
  • Average Non-cash Items over 3 years is $115944.9, with a median of $117952.5 recorded in 2024.
  • Peak YoY movement for Non-cash Items: skyrocketed 86.03% in 2024, then tumbled 60.69% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $187634.0 in 2023, then fell by 27.04% to $136899.0 in 2024, then rose by 17.88% to $161372.0 in 2025.
  • Per Business Quant, the three most recent readings for INM's Non-cash Items are $161372.0 (Q4 2025), $50055.0 (Q3 2025), and $72549.0 (Q2 2025).